Audited Financial Results for quarter and year ended on 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 1.2 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved standalone audited results for Q4 FY25 and full year ended 31 March 2025, with an unmodified (clean) audit opinion from Rajani Shah & Co. Revenue from operations rose modestly to about Rs. 5.70 crore in FY25 from Rs. 5.47 crore in FY24, a growth of around 4%. Profit after tax jumped sharply to approximately Rs. 1.28 crore from just Rs. 0.23 crore in FY24. The company also wrote off Rs. 89.90 lakh of trade receivables and Rs. 29.63 lakh of advances during the year, treating these as regular P&L expenses. Separately, the board updated its Nomination & Remuneration and POSH policies, and recommended appointing M/s. D.G. Bhimani & Associates as secretarial auditor for five years (FY26-FY30), pending shareholder approval.
The headline PAT surge looks strong, but quality of earnings is weak — nearly Rs. 1.20 crore of write-offs means the actual cash profit picture is much less rosy. The balance sheet is a red flag: other equity is deeply negative at Rs. (9.56) crore, leaving total equity at just Rs. 0.35 crore, while total borrowings of around Rs. 3.94 crore push the debt-to-equity ratio above 11x. Existing shareholders should watch capital structure and working-capital health closely despite the clean audit opinion.